Financhill
Sell
30

INKT Quote, Financials, Valuation and Earnings

Last price:
$11.69
Seasonality move :
-20.14%
Day range:
$11.50 - $12.38
52-week range:
$4.56 - $76.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
20K
Avg. volume:
20.4K
1-year change:
68.47%
Market cap:
$54M
Revenue:
--
EPS (TTM):
-$3.03

Earnings Data

Next earnings date for INKT
Mar 17
2026
Most recent earnings per share
-$0.65
Beat by $0.21
(Nov 14/2025)
Consensus Estimate
-$0.86
(Nov 14/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

INKT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/17/2026 Q4 -- -- -- -$0.68 --
11/14/2025 Q3 -- -- -$0.65 -$0.86 $0.21
08/14/2025 Q2 -- -- -$1.06 -$0.55 -$0.52
05/13/2025 Q1 -- -- -$0.70 -$0.61 -$0.09
03/18/2025 Q4 -- -- -$0.62 -$0.50 -$0.12
11/14/2024 Q3 -- -- -$0.05 -$0.80 $0.75
08/13/2024 Q2 -- -- -$0.07 -$0.97 $0.89
05/14/2024 Q1 -- -- -$0.11 -$1.53 $1.42
03/21/2024 Q4 -- -- -$0.16 -$1.53 $1.38
11/09/2023 Q3 -- -- -$0.15 -- --
08/10/2023 Q2 -- -- -$0.18 -- --
05/11/2023 Q1 -- -- -$0.17 -- --
03/21/2023 Q4 -- -- -$0.23 -- --
11/03/2022 Q3 -- -- -$0.19 -- --
08/09/2022 Q2 -- -- -$0.18 -- --
05/10/2022 Q1 -- -- -$0.23 -- --
03/18/2022 Q4 -- -- -$0.17 -- --
11/29/2021 Q3 -- -- -$0.59 -- --
06/30/2021 Q2 -- -- -$2.23 -- --
03/31/2021 Q1 -- -- -$0.12 -- --
12/31/2020 Q4 -- -- -$0.54 -- --
09/30/2020 Q3 -- -- -$2.13 -- --

MiNK Therapeutics, Inc. Earnings Questions

  • How Much did MiNK Therapeutics, Inc. Generate in Revenue Last Quarter?

    MiNK Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did MiNK Therapeutics, Inc. Beat Earnings Last Quarter?

    MiNK Therapeutics, Inc. announced earnings per share of -$0.65 which represents a beat of analyst forecast a -$0.86 per share.

  • Is MiNK Therapeutics, Inc. Profitable?

    MiNK Therapeutics, Inc. reported -$43.7K that represents -$0.01 per share over the last quarter.

  • What is the Analyst Consensus for MiNK Therapeutics, Inc. EPS Next Year?

    MiNK Therapeutics, Inc.'s earnings are forecast to decrease from -$2.86 per share to -$2.67 per share next year representing a decrease of -7.41%.

  • When is MiNK Therapeutics, Inc.'s Earnings Date?

    MiNK Therapeutics, Inc.'s next earnings date is March 17, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 6

SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.

Buy
62
PRAX alert for Dec 6

Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.

Sell
13
PSN alert for Dec 6

Parsons Corp. [PSN] is down 21.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock